Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Cancer researchers are rethinking clinical trials in response to the coronavirus. This reimagining of clinical trials is a reaction to the challenges posed by the pandemic. The specifics of these changes are not detailed, but the coronavirus has prompted a shift in approach.